Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC

References

• Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010; 7:277 - 85; http://dx.doi.org/10.1038/nrurol.2010.47; PMID: 20448661
   PubMed Web of Science ®Google Scholar
• Pavlovich CP, Schmidt LS. Searching for the hereditary causes of renal-cell carcinoma. Nat Rev Cancer 2004; 4:381 - 93; http://dx.doi.org/10.1038/nrc1364; PMID: 15122209
   PubMed Web of Science ®Google Scholar
• Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010; 463:360 - 3; http://dx.doi.org/10.1038/nature08672; PMID: 20054297
   PubMed Web of Science ®Google Scholar
• Guo G, Gui Y, Gao S, Tang A, Hu X, Huang Y, et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 2012; 44:17 - 9; http://dx.doi.org/10.1038/ng.1014; PMID: 22138691
   PubMed Web of Science ®Google Scholar
• Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A, Wang S, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012; 44:751 - 9; http://dx.doi.org/10.1038/ng.2323; PMID: 22683710
   PubMed Web of Science ®Google Scholar
• Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469:539 - 42; http://dx.doi.org/10.1038/nature09639; PMID: 21248752
   PubMed Web of Science ®Google Scholar
• Duns G, Hofstra RM, Sietzema JG, Hollema H, van Duivenbode I, Kuik A, et al. Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development. Hum Mutat 2012; 33:1059 - 62; http://dx.doi.org/10.1002/humu.22090; PMID: 22461374
   PubMed Web of Science ®Google Scholar
• Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228 - 31; http://dx.doi.org/10.1126/science.1196333; PMID: 20826764
   PubMed Web of Science ®Google Scholar
• Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363:1532 - 43; http://dx.doi.org/10.1056/NEJMoa1008433; PMID: 20942669
   PubMed Web of Science ®Google Scholar
• Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011; 43:875 - 8; http://dx.doi.org/10.1038/ng.907; PMID: 21822268
   PubMed Web of Science ®Google Scholar
• Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 2012; 33:100 - 3; http://dx.doi.org/10.1002/humu.21633; PMID: 22009941
   PubMed Web of Science ®Google Scholar
• van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009; 41:521 - 3; http://dx.doi.org/10.1038/ng.349; PMID: 19330029
   PubMed Web of Science ®Google Scholar
• Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 2012; 488:100 - 5; http://dx.doi.org/10.1038/nature11284; PMID: 22832583
   PubMed Web of Science ®Google Scholar
• Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 2012; 109:3879 - 84; http://dx.doi.org/10.1073/pnas.1121343109; PMID: 22343534
   PubMed Web of Science ®Google Scholar
• Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476:298 - 303; http://dx.doi.org/10.1038/nature10351; PMID: 21796119
   PubMed Web of Science ®Google Scholar
• Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 2012; 488:106 - 10; http://dx.doi.org/10.1038/nature11329; PMID: 22820256
   PubMed Web of Science ®Google Scholar
• Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330:1410 - 3; http://dx.doi.org/10.1126/science.1194472; PMID: 21051595
   PubMed Web of Science ®Google Scholar
• Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43:668 - 72; http://dx.doi.org/10.1038/ng.855; PMID: 21642991
   PubMed Web of Science ®Google Scholar
• White AE, Harper JW. Cancer. Emerging anatomy of the BAP1 tumor suppressor system. Science 2012; 337:1463 - 4; http://dx.doi.org/10.1126/science.1228463; PMID: 22997315
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148 - 59; http://dx.doi.org/10.1056/NEJMra072067; PMID: 18337604
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683 - 92; http://dx.doi.org/10.1016/j.cell.2007.01.029; PMID: 17320506
   PubMed Web of Science ®Google Scholar
• Smits KM, Schouten LJ, van Dijk BA, Hulsbergen-van de Kaa CA, Wouters KA, Oosterwijk E, et al. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis. Clin Cancer Res 2008; 14:782 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-07-1753; PMID: 18245539
   PubMed Web of Science ®Google Scholar
• Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, et al. Promoter hypermethylation profile of kidney cancer. Clin Cancer Res 2004; 10:3972 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-04-0175; PMID: 15217927
   PubMed Web of Science ®Google Scholar
• Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994; 91:9700 - 4; http://dx.doi.org/10.1073/pnas.91.21.9700; PMID: 7937876
   PubMed Web of Science ®Google Scholar
• Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55:4525 - 30; PMID: 7553621
   PubMed Web of Science ®Google Scholar
• Costa VL, Henrique R, Ribeiro FR, Pinto M, Oliveira J, Lobo F, et al. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer 2007; 7:133; http://dx.doi.org/10.1186/1471-2407-7-133; PMID: 17645803
   PubMed Web of Science ®Google Scholar
• Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD, et al. Multigene methylation analysis of Wilms’ tumour and adult renal cell carcinoma. Oncogene 2003; 22:6794 - 801; http://dx.doi.org/10.1038/sj.onc.1206914; PMID: 14555992
   PubMed Web of Science ®Google Scholar
• Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009; 69:4674 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-09-0146; PMID: 19470766
   PubMed Web of Science ®Google Scholar
• Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58:3455 - 60; PMID: 9699680
   PubMed Web of Science ®Google Scholar
• Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998; 95:6870 - 5; http://dx.doi.org/10.1073/pnas.95.12.6870; PMID: 9618505
   PubMed Web of Science ®Google Scholar
• Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57:808 - 11; PMID: 9041175
   PubMed Web of Science ®Google Scholar
• Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A 1998; 95:8698 - 702; http://dx.doi.org/10.1073/pnas.95.15.8698; PMID: 9671741
   PubMed Web of Science ®Google Scholar
• Cairns P. Gene methylation and early detection of genitourinary cancer: the road ahead. Nat Rev Cancer 2007; 7:531 - 43; http://dx.doi.org/10.1038/nrc2170; PMID: 17585333
   PubMed Web of Science ®Google Scholar
• Maradeo ME, Cairns P. Translational application of epigenetic alterations: ovarian cancer as a model. FEBS Lett 2011; 585:2112 - 20; http://dx.doi.org/10.1016/j.febslet.2011.03.016; PMID: 21402071
   PubMed Web of Science ®Google Scholar
• Issa JP, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009; 15:3938 - 46; http://dx.doi.org/10.1158/1078-0432.CCR-08-2783; PMID: 19509174
   PubMed Web of Science ®Google Scholar
• Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99:3740 - 5; http://dx.doi.org/10.1073/pnas.052410099; PMID: 11891299
   PubMed Web of Science ®Google Scholar
• Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 2009; 1:177 - 200; http://dx.doi.org/10.2217/epi.09.14; PMID: 22122642
   PubMed Web of Science ®Google Scholar
• Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378 - 85; http://dx.doi.org/10.1038/ng1909; PMID: 17072317
   PubMed Web of Science ®Google Scholar
• Greenfield A, Carrel L, Pennisi D, Philippe C, Quaderi N, Siggers P, et al. The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet 1998; 7:737 - 42; http://dx.doi.org/10.1093/hmg/7.4.737; PMID: 9499428
   PubMed Web of Science ®Google Scholar
• Tsuchiya KD, Greally JM, Yi Y, Noel KP, Truong JP, Disteche CM. Comparative sequence and x-inactivation analyses of a domain of escape in human xp11.2 and the conserved segment in mouse. Genome Res 2004; 14:1275 - 84; http://dx.doi.org/10.1101/gr.2575904; PMID: 15197169
   PubMed Web of Science ®Google Scholar
• Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002; 167:57 - 60; http://dx.doi.org/10.1016/S0022-5347(05)65382-7; PMID: 11743275
   PubMed Web of Science ®Google Scholar
• Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. DNA methylation: bisulphite modification and analysis. Nat Protoc 2006; 1:2353 - 64; http://dx.doi.org/10.1038/nprot.2006.324; PMID: 17406479
   PubMed Web of Science ®Google Scholar
• Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997; 25:4422 - 6; http://dx.doi.org/10.1093/nar/25.21.4422; PMID: 9336479
   PubMed Web of Science ®Google Scholar
• Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001; 29:E65 - 5; http://dx.doi.org/10.1093/nar/29.13.e65; PMID: 11433041
   PubMedGoogle Scholar
• Sandovici I, Leppert M, Hawk PR, Suarez A, Linares Y, Sapienza C. Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum Mol Genet 2003; 12:1569 - 78; http://dx.doi.org/10.1093/hmg/ddg167; PMID: 12812984
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366:883 - 92; http://dx.doi.org/10.1056/NEJMoa1113205; PMID: 22397650
   PubMed Web of Science ®Google Scholar
• Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 2006; 66:5021 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-3365; PMID: 16707423
   PubMed Web of Science ®Google Scholar
• Ibragimova I, Ibáñez de Cáceres I, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, et al. Global reactivation of epigenetically silenced genes in prostate cancer. Cancer Prev Res (Phila) 2010; 3:1084 - 92; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0039; PMID: 20699414
   PubMed Web of Science ®Google Scholar
• Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 1999; 18:1313 - 24; http://dx.doi.org/10.1038/sj.onc.1202415; PMID: 10022813
   PubMed Web of Science ®Google Scholar
• Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 1997; 57:2229 - 37; PMID: 9187126
   PubMed Web of Science ®Google Scholar
• Barrera V, Peinado MA. Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale. Nucleic Acids Res 2012; 40:11490 - 8; http://dx.doi.org/10.1093/nar/gks928; PMID: 23066096
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010; 8:e1000533; http://dx.doi.org/10.1371/journal.pbio.1000533; PMID: 21085693
   PubMed Web of Science ®Google Scholar
• Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994; 54:6353 - 8; PMID: 7987828
   PubMed Web of Science ®Google Scholar
• Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21:5427 - 40; http://dx.doi.org/10.1038/sj.onc.1205600; PMID: 12154405
   PubMed Web of Science ®Google Scholar
• Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23:1327 - 37; http://dx.doi.org/10.1101/gad.1777409; PMID: 19487573
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647 - 58; http://dx.doi.org/10.1053/j.gastro.2007.05.022; PMID: 17681183
   PubMed Web of Science ®Google Scholar
• Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A 2000; 97:10014 - 9; http://dx.doi.org/10.1073/pnas.180316197; PMID: 10954755
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russell DW. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 2001.
   Google Scholar
• Foch JaT. G. Chapter 5: New Human Tumor Cell Lines In: Foch J, ed. Human Tumor Cells in Vitro. New York and London: Plenum Press, 1975:115-59.
   Google Scholar
• Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261 - 82; http://dx.doi.org/10.1016/0022-2836(87)90689-9; PMID: 3656447
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655 - 63; http://dx.doi.org/10.1097/00000478-198210000-00007; PMID: 7180965
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III. Chapter 43 Kidney. AJCC Cancer Staging Manual Seventh Edition 2009:479-90.
   Google Scholar